1435935-50-4

Upstream product

• 100-39-0 benzyl bromide 
• 1374139-12-4 (3-(benzyloxy)-2-{[(tert-butyl)dimethylsilyl]oxy}-5-methylphenyl)methanol 
• 1374139-11-3 3-(benzyloxy)-2-{[(tert-butyl)dimethylsilyl]oxy}-5-methylbenzaldehyde 
• 1374139-10-2 3-(benzyloxy)-5-bromo-2-{[(tert-butyl)dimethylsilyl]-oxy}benzaldehyde 
• 1374139-17-9 11-(benzyloxy)-4-methoxy-9-methyl-5-oxo-5,7-dihydrodibenzo-[b,g][1,5]-dioxocine-3-carbaldehyde 
• 697302-70-8 3-(benzyloxy)-5-bromo-2-hydroxybenzaldehyde 
• 1374139-16-8 6-[2-(benzyloxy)-6-(hydroxymethyl)-4-methylphenoxy]-3-formyl-2-methoxybenzoic acid 
• 24677-78-9 2,3-dihydroxybenzaldehyde 
• 1374139-15-7 methyl 6-[2-(benzyloxy)-6-(hydroxymethyl)-4-methylphenoxy]-3-formyl-2-methoxybenzoate 
• 1374139-14-6 methyl 6-{2-(benzyloxy)-4-methyl-6-{[(tetrahydro-2H-pyran-2-yl)oxy]methyl}phenoxy}-3-formyl-2-methoxybenzoate 
• 86734-59-0 3-benzyloxy-2-hydroxybenzaldehyde 
• 1374139-13-5 3-(benzyloxy)-2-(hydroxy)-5-methylbenzenemethanol 

Relevant academic research and scientific papers

Synthesis and evaluation of the analogues of penicillide against cholesterol ester transfer protein

A series of penicillide analogues, with modifications at C-3 and C-9 positions, are synthesized as potential cholesteryl ester transfer protein (CETP) inhibitors. The preliminary in vitro inhibition assay provided some valuable structure-activity relationship information about penicillide. Copyright